Skip to main content
. Author manuscript; available in PMC: 2020 Nov 6.
Published in final edited form as: Nature. 2020 May 6;583(7814):90–95. doi: 10.1038/s41586-020-2265-1

Extended Data Table 2. Description of the NIHR BioResource - Primary Immunodeficiency cohort.

High-level clinical description and relevant clinical features were provided by recruiting clinicians. Index cases are patients recruited as sporadic cases or probands in pedigrees, and determined to be genetically unrelated by pairwise comparisons of common SNP genotypes in the WGS data. Numbers in brackets refer to the percentage of index cases in each category. Total number of patients is the sum of index cases and any affected relatives sequenced in this study.

Clinical Description Index Cases Familial Disease Male Paediatric Disease Onset Antibody (IgG/A/M) Deficiency Auto-immune Features Low CD4+ T cells Malignancy Total Sequenced Patients
Antibody Defect 122 21
(17)
52
(43)
41
(34)
122
(100)
22
(18)
12
(10)
7
(6)
144
CVID 443 50
(11)
220
(50)
103
(23)
443
(100)
126
(28)
95
(21)
35
(8)
469
CID 141 26
(18)
71
(50)
77
(54)
141
(100)
26
(18)
70
(49)
19
(13)
156
SCID 12 3
(25)
8
(67)
12
(100)
0 0 10
(83)
0 12
Phagocyte disorder 23 3
(13)
8
(35)
12
(52)
1
(4)
3
(13)
4
(17)
3
(13)
27
Severe Auto-immunity 52 6
(12)
28
(54)
14
(27)
22
(42)
52
(100)
8
(15)
6
(12)
53
Auto-inflamatory Syndrome 26 3
(12)
11
(42)
7
(27)
3
(12)
19
(73)
6
(23)
1
(4)
27
Unspecified PID 67 7
(11)
27
(42)
18
(28)
1
(2)
2
(3)
3
(5)
4
(6)
86
Total 886 119
(13)
425
(48)
284
(32)
733
(83)
250
(28)
208
(23)
75
(8)
974